Ogilvy CommonHealth Asia Pacific have appointed Dr Robert Liversage as its director of scientific and editorial in its Australian office, strengthening their Australian team.
Full release below.
Ogilvy CommonHealth strengthen team in healthcare communications with key scientific hire
The creation of this new key role bolsters the scientific service offer and credentials of this integrated health focused communications agency
Sydney Australia January 2014 – Ogilvy CommonHealth (OCH) announced today that they have appointed Dr Robert Liversage as their Director of Scientific & Editorial Services. The newly created role will see Dr Liversage take responsibility for content development, scientific council and medical advice across all areas of the business from prescription medications to OTC and pharmacy brands, and from medical education to disease awareness programmes.
Robert has a Neuroscience and Neuropharmacology PhD from the University of Leeds (UK) and spent several years in high-science, medical writing roles in the UK before relocating to Australia. Since 2008 he has been working within the editorial departments of Australian medical communications businesses and healthcare advertising agencies writing within the pharmaceutical space, leading the editorial and medical elements across both promotional and education programmes. He has a plethora of experience across disease areas spanning Oncology, Mental Health, Diabetes, Respiratory, CV, Dermatology, medical devices and Infectious Diseases.
Gary Pattison, Ogilvy CommonHealth Group Managing Director said “I am thrilled that Rob will be joining our growing, expert team at Ogilvy. He has a solid track record and a reputation as one of the best in the business.”
Pattison went on to say, “At OCH we have spent the last 6-8 months looking carefully at our business, our structure and how we add value to our clients brands in this ever-changing world of health and wellness. We live and breath change here – we never stand still. We must offer excellence in client service and creative ideation of course – but none of this matters if you get the science wrong. Rob is a key hire in this respect as we plan for the future of the business and the future of our clients business.”
Rohit Sahgal, Director for Ogilvy CommonHealth commented “Staying one step ahead is a tradition at Ogilvy, and doing that in the area of scientific innovation has been a key part of a multi-faceted specialist strategy. Rob’s appointment reinforces our commitment to providing cutting edge solutions and building enduring client partnerships.”
Ogilvy & Mather
Ogilvy & Mather is one of the largest marketing communications companies in the world. It was named both the Cannes Lions Network of the Year and the EFFIEs World’s Most Effective Agency Network for two consecutive years, 2012 and 2013. The company is comprised of industry leading units in the following disciplines: advertising; public relations and public affairs; branding and identity; shopper and retail marketing; health care communications; direct, digital, promotion and relationship marketing; consulting, research and analytics; branded content and entertainment; and specialist communications. O&M services Fortune Global 500 companies as well as local businesses through its network of more than 500 offices in 126 countries. It is a WPP company (NASDAQ: WPPGY). For more information, visit http://www.ogilvy.com/, or follow Ogilvy on Twitter at @Ogilvy and on Facebook.com/Ogilvy.